Somatropin Genheal

Somatropin Genheal

Genheal™ (somatropin [rDNA origin] for injection) is one of the leading rHGH in China that has been widely used in more than 300 Class A hospitals for pediatric, burn, surgery, epidemiology and other areas of clinical treatment. Genheal™ conform both domestic and international quality standards and is one of the best rHGH products on the market today.

Genheal™ is approved by the Food and Drug Administration (FDA) for the following indications:
• Growth hormone deficiency in children with long-term treatment
• Treatment of metabolic diseases and AIDS-related wasting
• Prader –Willi syndrome caused by long-term treatment of children with growth deficiencies
• Continued after birth, intrauterine growth retardation short stature
• Adults with growth hormone deficiency (GHD)
• Long-term treatment of patients with Turner syndrome
• Idiopathic short stature
• Short bowel syndrome
• Pediatric renal transplantation before renal failure related to lack of growth
• SHOX gene deficiency

4mg (10IU) vial/x 1